Abstract
Although the systematic collection of information on the endocrine pancreas dates from the anatomical description of the islets of Langerhans, much had previously been learned about diabetes by the ancient observers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
C. P. Bryan (trans.), 1931. Papyrus Ebers. New York: Appleton.
K. F. Wellman, and B. W. Volk, 1977. Historical review, in: The Diabetic Pancreas (B. W. Volk and K. F. Wellman, eds.). New York/London: Plenum.
K. C. Wong, and L.-T. Wu, 1932. History of Chinese Medicine. Tientsin, China: Tientsin Press.
D. R. Owens, 1986. Human Insulin: Clinical Pharmacological Studies in Normal Man, Hingham, Massachusetts: MTP Press.
E. J. Leopold, 1930. Aretaeus the Cappadocian and his contribution in diabetes mellitus, Ann. Med. Hist. 11:424.
D. Guthrie, 1946. A History of Medicine,Philadelphia: Lippincott.
E. F. Cordell, 1909. Aretaeus of Cappadocia, Johns Hopkins Hosp. Bull. 20:371–377.
A. Castiglioni, 1927; E. B. Krumbhaer (trans.), 1941. A History of Medicine. New York: Alfred A. Knopf.
Avicenna, Canon of Medicine, cited in: Chronik der Medizin [Chronicle of Medicine], 1993 (H. Schott). Dortmund: Harenberg.
J. H. Braasch, 1928. Historical facts in diabetes, Ann. Med. Hist. 10:387.
R. H. Major, 1954. A History of Medicine. Springfield, Illinois: Charles Thomas.
T. Willis, 1679. Pharmaceutice rationalis; or An Exercitation of the Operations of Medicines in Humane [sic] Bodies. Showing the signs, causes, and cures of most distempers incident thereunto. London: Dring, Harper, and Leigh.
P. J. Fitzgerald, 1980. Medical anecdotes concerning some diseases of the pancreas, in: The Pancreas Pancreas (P. J. Fitzgerald and A. B. Morrison, eds.). Baltimore and London: Williams and Wilkins, pp. 1–29.
W. Cullen, 1787. The First Lines of the Practice of Physic, Edinburgh.
C. A. Trommer, 1841. Unterscheidung von Gummi-Traubenzucker und Rohrzucker [Differentiation between gum-glucose and cane sugar], Ann. Chem. Pharm. 39:360.
J. F. Heller, 1844. Über den Nachweis von Zucker im Harn [On the detection of sugar in the urine], Arch. Physiol. Pathol. Chemie Microscopie, p. 133.
H. C. Fehling, 1850. Eine neue Nachweismethode für von Zucker in Harn [A new method for the detection of glucose in the urine], Z. Phys. Chem. 2:16.
G. B. Morgagni, 1765. De sedibus et causis morborum per anatomen indagatis [On the seats and causes of diseases as revealed by the anatomist], in: Opera omnia [Complete Works] (G. B. Morgagni), Tom. 3. Venice: Remondiniana.
T. Cawley, 1788. A singular case of diabetes, consisting entirely in the quality of the urine, with an inquiry into the different theories of that disease, London Med. J. 9:286–308.
J. Lieutaud, 1756. Precis de médicine pratique [Compendium of practical medicine]. Paris.
R. Bright, 1833. Cases and observations connected with disease of the pancreas and duodenum, Med. Chir. Transact. 18:1.
J. A. Fles, 1864. Ein Fall von Diabetes Mellitus mit Atrophie der Leber und des Pankreas [A case of diabetes mellitus with atrophy of the liver and pancreas], Arch. Holländ Beitr. Heilk. 3:187.
E. Ancelet, 1856. L’anatomie pathologique du pancréas [Pathologic anatomy of the pancreas]. Paris: Rignoux.
N. Wood, 1893. Treatment of diabetes by pancreatic extract, Br. Med. J. 1:68.
H. W. G. MacKenzie, 1893. Treatment of diabetes by means of pancreatic juice, Br. Med. J. 1:63.
R. Virchow, 1871. Die Cellularpathologie [Cellular Pathology], 4th ed. Berlin: Hirschwald.
P. Langerhans, 1869. Beiträge zur mikroskopischen Anatomie der Bauchspeicheldrüse [Contributions to the microscopic anatomy of the pancreas]. Berlin: G. Lange.
P. Langerhans; Morrison, H. (trans.), 1937. Contributions to the Microscopic Anatomy of the Pancreas. Baltimore: Johns Hopkins Press.
W. Kühne, and A. S. Lea, 1878. Beobachtungen über die Absonderung des Pankreas [Investigations on the secretions of the pancreas], Untersuchungen Physiol. Instit. Univ. Heidelberg 2:448–487.
E. Laguesse, 1893. Sur la formation des îlots de Langerhans dans le pancréas [On the formation of the islets of Langerhans in the pancreas], C. R. Soc. Biol. Paris 30:819–820.
E. Lancereaux, 1880. Le diabète maigre, ses symptomes, son évolution, son pronostic et son traitement [The meager diabetes, its symptoms, evolution, prognosis and treatment], Union Mèd. 29:161.
E. Lancereaux, 1899. Traité des maladies du foie et du pancréas [Treatise on the diseases of the liver and pancreas]. Paris: Doin.
E. Lancereaux, and M. Lackerbauer, W. S. Greenfield (trans.), 1880. Atlas of Pathological Anatomy. London: Churchill.
F. T. Frerichs, 1884. Ueber Diabetes [On Diabetes]. Berlin: Hirschwald.
B. P. Babkin, 1949. Pavlov: A Biography. Chicago: University of Chicago Press.
“Josef von Mering,” in: Biographisches Lexikon der hervorragenden Aerzte der letzten 50 Jahre [Biographical dictionary of famous physicians of the last 50 years] (L. Fischer, ed.), 1933. BerlinNienna: Urban and Schwarzenberg.
B. Naunyn, 1892. Klinik der Cholelithiasis [Clinics on Gallstone Disease]. Leipzig: F. C. W. Vogel.
M. Bliss, 1982. The Discovery of Insulin. Chicago: University of Chicago Press.
J. von Mering, and O. Minkowski, 1889–1890. Diabetes mellitus nach Pankreasexstirpation [Diabetes mellitus after pancreatectomy], Arch. Exp. Pathol. Pharm. 26:371–387.
B. Naunyn, 1925. Erinnerungen, Gedanken und Meinungen [Memories, Thoughts and Convictions]. Munich: J. S. Bergmann. See also: B. Naunyn; D. L. Cowen (trans.). 1994. Memories, Thoughts and Convictions, Canton, Massachusetts: Science History Publications USA.
G. Wolff, 1989. Paul Langerhans — die Inseln waren sein Schicksal [Paul Langerhans — the islands were his destiny], in: Diabetes in Medizin und Kulturgeschichte [Diabetes in the history of medicine and civilization] (D. von Engelhardt, ed.). Berlin: Springer, pp. 386–395.
J. Lane, 1908. Studies on the islets of the pancreas, Am. J. Anat. 7:409.
X. Arnozan, and L. Vaillard, 1884. Contribution à l’étude du pancréas du lapin, lésions provoquées par la ligature du canal de Wirsung [Contributions to the study of the pancreas of the rabbit, lesions produced by the ligature of the duct of Wirsung], Arch. Physiol. Norm. Pathol. 3:287.
E. L. Opie, 1901. The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islets of Langerhans, J. Exp. Med. 5:527.
L. W. Ssobolew, 1900. Über die Struktur der Bauchspeicheldrüse unter gewissen pathologischen Bedingungen [On the structure of the pancreas under certain pathologic conditions], Zentralorg. Allg. Path. 2:202–203.
L. W. Ssobolew, 1902. Zur normalen und pathologischen Morphologie der innern Secretion der Bauchspeicheldrüse [On the normal and pathologic morphology of the internal secretion of the pancreas], Arch. Path. Anat. 168:91–128.
G. E. Laguesse, 1902. Étude d’un pancréas de lapin, transformé en glande endocrine pure deux ans après résection de son canal excréteur [Study of a rabbit’s pancreas, transformed into a purely endocrine gland two years after resection of its excretory duct], C. R. Soc. Biot. Paris 38:854.
W. G. MacCallum, 1909. The relationship of the islets of Langerhans to glucosuria, Johns Hopkins Hosp. Bull. 20:265.
L. M. Dewitt, 1909. Morphology and physiology of islets of Langerhans in some vertebrates, J. Exp. Med. 7:193–239.
M. Barron, 1920. The relation of the islets of Langerhans to diabetes with special reference to cases of pancreatic lithiasis, Surg. Gynecol Obstet. 31:437–448.
Kamimura, Über die Bedeutung der Langerhansschen Inseln für den Kohlehydratstoffwechsel [On the importance of the islets of Langerhans for the metabolism of carbohydrates], cited in: Barron, M. 1920.(50)
H. White, 1893. On the treatment of diabetes mellitus by feeding on raw pancreas and by the subcutaneous injection of liquor pancreatis, Br. Med. J. 1:452.
G. Dubreuil, and M. Androdias, 1920. Dots de Langerhans géants chez un nouveau-né [Giant islets of Langerhans in a newborn], C. R. Soc. Biot. Paris 83:1490.
G. L. Zülzer, 1908. Über Versuche einer spezifischen Fermenttherapie des Diabetes [Experiments on a specific ferment treatment of diabetes], Zschr. exp. Path. 5:307.
G. L. Ziilzer, 1923. Über Acomaton, das Deutsche Insulin [On Acomaton, the German insulin], Med. Klin. 47:1551–1552.
O. Cohnheim, 1904. Über Kohlehydralverbrennung [On the combustion of carbohydrates], Z. Physiol. Chem. 42:401–410.
F. Battistini, 1893. Über zwei Fälle von Diabetes mellitus, mit Pankreassaft behandelt [On two cases of diabetes mellitus, treated with pancreatic juice], Ther. Monatsh. 7:494–498.
F. Blumenthal, 1898. Über Organtherapie des Diabetes Mellitus [On organotherapy of diabetes melitus], Zschr. Physiol. Diätet. Ther. 1:250–258.
E. Gley, 1922. Action des ectraits de pancréas sclérosé sur des chiens diabetiques, par exstirpation du pancréas [The action of an extract of the sclerosed pancreas on diabetes in dogs after extirpation of the pancreas], C. R. Soc. Biot. Paris 87:1322–1325.
F. G. Banting, C. H. Best, J. B. Collip, W. R. Campbell, and A. A. Fletcher, 1922. Pancreatic extracts in the treatment of diabetes mellitus. Preliminary report, Can. Med. Assoc. J. 12:141–146.
F. G. Banting, and C. H. Best, 1922. The internal secretion of the pancreas, J. Lab. Clin. Med. 7:251.
V. W. Pratt, 1956. Canadian Portraits. Oster,Banting, Penfield. Toronto: Clark, Irwin and Co.
Canadian Diabetes Association, “Timeline” (June 28, 1999); http://www.canoe.ca/HealthReference/diabetes_timeline.html.
A. O. Whipple, 1952. Islet cell tumors of the pancreas (Banting Memorial Lecture), Can. Med. Assoc. J. 66:334–342.
F. G. Banting, 1929. History of insulin, Edinburgh Med J 36:1, cited in: A. O. Whipple, 1952.
G. W. Manning, 1999. Experimental history: the discovery of insulin (July 1, 1999); http://web.idirect.com../discover/diabetes1.htm.
C. H. Best, 1942. Reminiscences of the researches which led to the discovery of insulin, Can. Med. Assoc. J. 47:398–400.
A. O. Whipple, 1960. A historical sketch of the pancreas, in: Surgical Diseases of the Pancreas (J. M. Howard and G. L. Jordan, Jr., eds.). Philadelphia: Lippincott.
J. J. R. Macleod, 1922. Source of insulin: Study of effect produced on blood sugar by extracts of pancreas on principle islets of fishes, J. Metab. Res. 2:149–172, cited in: A. O. Whipple, 1952.
J. De Meyer, 1909. Action de la sécrétion interne du pancréas sur différents organes et en particulier sur the sécrétion rénale [Action of the internal secretion of the pancreas on different organs and particularly on renal secretion], Arch. di Fisiol. 7:96.
F. G. Banting, Papers I: Banting to Best, October 26, 1923, cited in: M. Bliss, 1982.
D. A. Pyke, 1999, Preamble. The History of Diabetes (July 1, 1999); http://www.jacwiley.com.au/wileychi/diabetes/sample.html.
A. A. Fletcher, and W. R. Campbell, 1922. The blood sugar following insulin administration and the symptom complex of hypoglycemia, J. Metabol. Res. 2:637.
A. O. Whipple, 1938. The surgical therapy of hyperinsulinism, J Internat. Chir. 3:237–276.
S. Harris, From an address by Dr. Harris on the occasion of his citation by the Medical Association of Alabama, July 7, 1939, Birmingham, Alabama, cited in: A. O. Whipple, 1952.
J. P. Collip, 1923. The original method as used for the isolation of insulin in semipure form for the treatment of the first clinical cases, J. Biot. Chem., Scientific Proceedings XVII, 5:XI.
N. C. Paulesco, 1921. Action de l’extrait pancréatique [Action of pancreatic extract], C. R. Soc. Biol. Paris 85:555–559.
Nobel Archive, Miscellaneous Correspondence, Zülzer to G. Liljestrand, 22 December, 1923, 18 August 1924; Paulesco to the President of the Nobel Committee, 5 November 1923, 24 November 1923, cited in: M. Bliss, 1982.(38)
F. Galibert, 1981. Frederick Sanger: Prix Nobel de chimie pour la deuxième fois [Frederick Sanger: Nobel Prize for chemistry for the second time], Pathol. Biol. 29:5–6.
A. P. Ryle, F. Sanger, L. F. Smith, and R. Kitai, 1955. The disulphide bonds of insulin, Biochem. J. 60:541–546.
Nobel Foundation. 1980. The Nobel Prize in Chemistry 1980 (June 22, 1999);http://www.nobel.se/laureates/chemistry-1980.html.
R. S. Yalow, and S. A. Berson, 1959. Assay of plasma insulin in human subjects by immunological methods, Nature (London) 184:1648.
P. G. Katsoyannis, A. Tometsko, and K. Fukuda, 1963. Insulin peptides IX. The synthesis of the A-chain of insulin and its combination with natural B-chain to generate insulin activity, J. Amer. Chem. Soc. 85:2863.
P. Sieber, B. Kamber, A. Hartmann, A. Jöhl, B. Riniker, and W. Rittel, 1974. Totalsynthese von Humaninsulin unter gezielter Bildung der Disulfidbindungen [Total synthesis of human insulin aiming at the formation of the disulphide links], Heiv. Chim. Acta 57:2617–2621.
R. Crea, A. Kraszewski, T. Hirose, and K. Itakura, 1978. Chemical synthesis of genes for human insulin, Proc. Natl. Acad. Sci. U.S.A. 75:5765–5769.
A. G. Nicholls, 1902. Simple adenoma of the pancreas arising from an island of Langerhans, J. Med. Res. 3:385.
K. A. Heiberg, 1914. Die Krankheiten des Pancreas [Diseases of the Pancreas]. Wiesbaden: Bergmann.
Fabozzi, 1903. Über die Histogenese des primären Krebses des Pankreas [On the histogenesis of primary pancreatic cancer], Ziegiers. Beitz. Pathol. 34:199–214.
A. Vecchi, 1914. Carcinoma delle isole di Langerhans in un pancreas aberrante [Carcinoma of the islets of Langerhans in an ectopic pancreas], Arch. Sci. Med. (Ital) 38:277.
B. V. White Jr., and E. F. Gildea, 1937. Adenoma of pancreas and hyperinsulinism; report of case with studies of effects of emotions, of changes in diet and of administration of acids and of alkali on symptoms of hypoglycemia, N. Engl. J. Med. 217:307–313.
F. J. Lang, 1925. Ueber einige Geschwulstbildungen des Pankreas [On some tumors of the pancreas], Arch. Path. Anat. 257:235–248.
A. Dagradi, 1997. Clinically silent islet cell tumors, in: Textbook of Bilio-Pancreatic Diseases, Volume I (W. Hess and G. Berci, eds.). Padua: Piccin.
S. Harris, 1924. Hyperinsulinism and dysinsulinism, JAMA 83:729–733.
J. T. Parker, and C. S. Finley, 1924. Some results obtained by the treatment of nervous phenomena with glucose, Proc. Soc. Exper. Biol. Med. 21:517–519.
S. Warren, 1926. Adenomas of the islets of Langerhans, Am. J. Path. 2:335–340.
R. M. Wilder, 1940. Clinical Diabetes Mellitus and Hyperinsulinism. Philadelphia: W. B. Saunders.
R. M. Wilder, F. N. Allan, M. H. Power, and H. E. Robertson, 1927. Carcinoma of islands of pancreas, hyperinsulinism and hypoglycemia, JAMA 89:348–355.
W. N. McClenahan, G. W. Norris, 1929. Adenoma of the islets of Langerhans with associated hypoglycemia, Am. J. Med. Sci. 177:93.
W. Thalhimer, and F. D. Murphy 1928. Carcinoma of the islands of the pancreas. Hyperinsulin-ism and hypoglycemia, JAMA 91:89.
G. Howland, W. R. Campbell, E. J. Maltby, and W. L. Robinson, 1929. Dysinsulinsm: convulsions and coma due to islet cell tumor of the pancreas, with operation and cure, JAMA 93:674.
A. D. Carr, R. Parker, E. Grove, A. O. Fisher, and S. W. Larrimore, 1931. Adenoma of the pancreas, JAMA 96:1363.
V. K. Frantz, 1940. Tumors of islet cells with hyperinsulinism. Benign, malignant and questionable, Ann. Surg. 112:161–176.
A. O. Whipple, 1944. Hyperinsulinism in relation to pancreatic tumors (Trimble Lecture), Surgery 16:289–305.
A. O. Whipple, The Memoirs of Allen O. Whipple 1881–1963 (unpublished).
J. M. T. Finney, and J. M. T. Finney, Jr., 1928. Resection of the pancreas, Ann. Surg. 88:584.
V. C. David, 1940. The indications and results of pancreatectomy for hypoglycemia, Surgery 8:212.
N. H. Moss, and J. E. Rhoads, 1960. Hyperinsulinism and islet cell tumors of the pancreas, in: Surgical Diseases of the Pancreas (J. M. Howard and G. L. Jordan, Jr., eds.). Philadelphia-Lippincott.
H. E. Simon, 1934. Surgery in treatment of hyperinsulinism, Southern Surgeon 3:211–226.
J. M. McCaughan, and G. O. Broun, 1937. Value of partial pancreatectomy in convulsive states associated with hypoglycemia, Ann. Surg. 105:354–369.
J. T. Priestley, M. W. Comfort, and J. Radcliffe, 1944. Total pancreatectomy for hyperinsulinism, Ann. Surg. 119:211.
J. M. Waugh, C. S. Dixon, O. T. Clagett, J. L. Bollman, R G Sprague, and M. W. Comfort, 1946. Total pancreatectomy. A symposium presenting four successful cases and a report on metabolic observations, Proc. Staff Meet. Mayo Clin. Rochester 21:25.
O. Olsson, 1963. Angiographie diagnosis of an islet cell tumor of the pancreas, Acta Chir. Scand. 126:346.
J. Göthlin, A. Lunderquist, and U. Tylén, 1974. Selective phlebography of the pancreas, Acta Radiol. Diagn. 15:474.
S. G. Ingemansson, A. Lunderquist, R. Lövdal, and S. Tibblin, 1975. Portal and pancreatic vein catheterization with blood sampling and radioimmunologic determination of insulin, Surg. Gynecol. Obstet. 141:705.
W. H. Bakker, E. P. Krenning, W. A. P. Breeman, J. W. Koper, P. P. M. Kooji, J. C. Reubi, J. G. Klijn, T. J. Visser, R. Doctor, and S. W. J Lamberts, 1990. In vivo use of a radioiodinated somatostatin analogue, J. Nuc. Med. 31:1501.
S. S. Dunn, R. G. M. McLetchie, and H. L. Sheehan, 1943. Necrosis of islets of Langerhans produced experimentally, Lancet 1:484.
A. Brunschwig, J. G. Allen, F. M. Owens, and T. F. Thornton, 1944. Alloxan in the treatment of insulin producing islet cell carcinoma of the pancreas, JAMA 124:212.
A. Drash, and F. W. Wolff, 1964. Drug therapy in leucin sensitive hypoglycemia, Metabolism 13:487.
S. J. Bleicher, F. Chowdhury, and M. G. Goldner, 1964. Thiazide therapy in hypoglycemia of metastatic insulinoma, Clin. Res. 12:45.
P. Brazeau, W. Vale, R. Burgus, N. Ling, M. Butcher, M. Rivier, and R. Guillemin, 1973. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone, Science 179:77–79.
P. Gorden, R. J. Comi, P. N. Maton, and V. W. L. Go, 1989. Somatostatin and somatostatin analogue (SMS 201–995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non neoplastic diseases of the gut, Ann. Intern. Med. 110:35–50.
J. L. Ching, J. Anderson, S. J. Williams, D. H. Cahr, and S. R. Bloom, 1986. Remission of symptoms during long-term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue, Br. Med. J. (Clin. Res.) 292:981–982.
R. R. Herr, H. K. Jahnke, and A. D. Angondelis, 1967. The structure of streptozotocin, J. Am. Chem. Soc. 88:480.
I. M. Murray-Lyon, J. Cassar, and R. Coulson, 1971. Further studies on streptozotocin therapy for multiple hormone-producing islet cell carcinoma, Gut 12:717.
A. S. Mason, 1953. Functioning malignant islet cell tumor of the pancreas, Proc. Roy. Soc. Med. 46:305–306.
F. Kümmerle, 1983. Chirurgie des endokrinen Pancreas [Surgery of the Endocrine Pancreas], Thieme, Stuttgart/New York.
R. L. Cecil, 1909. A study of the pathologic anatomy of the pancreas in ninety cases of diabetes, Am. J. Anat 7:266.
E. J. Horgan, 1920. The histogenesis of carcinoma of the islets of the pancreas, J. Lab. Clin. Med. 5:429.
A. W. Phillips, 1931. Hypoglycemia associated with hypertrophy of the islands of Langerhans, JAMA 96:1195–1198.
V. K. Frantz, 1944. Adenomatosis of islet cells with hyperinsulinism, Ann. Surg. 119:824–844.
I. McQuarrie, 1954. Idiopathic spontaneously occurring hypoglycemia in infants. Clinical significance of problem and treatment, Am. J Dis. Child. 87:399.
G. F. Laidlaw, 1938. Nesidioblastoma, the islet tumor of the pancreas, Am. J. Path. 14:125.
E. A. Graham, and A. F. Hartmann, 1934. Subtotal resection of the pancreas for hypoglycemia, Surg. Gynecol. Obstet. 59:474.
B. Glaser, and H. Landau, 1990. Long-term treatment with somatostatin analogue SMS 201–995: Alternative to pancreatectomy in persistent hyperinsulinaemia of insulin, Digestion 1:27–35.
B. H. Glaser, J. Hirsch, and H. Landau, 1993. Persistent hypoglycemia of infancy- Long-term octreotide treatment without pancreatectomy, J. Pediat 123:644–650.
P. S. Thornton, C. A. Alter, L. E. Katz, L. Baker, and C. A. Stanley, 1993. Short-and long-term use of octreotide in the treatment of congenital hyperinsulinism, J Pediat. 123:637–643.
H. P. G. Seckel, 1939. Postmortem hepatic glycogenolysis in hyperinsulinism and glycogen disease, J. Clin. Invest. 18:723.
H. H. Arkless, 1942. Coincidence of rhabdomyofibroma of diaphragm, idiopathic hypoglycemia and retroperitoneal sarcoma, Med. Bull. Vet. Admin. 19:225, cited in: N. H. Moss and J. E. Rhoads, 1960.(107)
J. S. Edkins, 1906. The clinical mechanism of gastric secretion, J. Physiol. (London) 34:133.
R. M. Zollinger, and D. Coleman, 1974. The Influences of Pancreatic Tumors on the Stomach. Springfield, Illinois: Charles C. Thomas.
I. M. Modlin, M. Kidd, I. N. Marks, and L. H. Tang, 1997. The pivotal role of John S. Edkins in the discovery of gastrin, World J. Surg. 21:226–234.
L. R. Dragstedt, H. A. Oberhelman, and C. A. Smith, 1951. Experimental hyperfunction of the gastric antrum with ulcer formation, Ann. Surg. 134:332–345.
R. M. Zollinger, and E. H. Ellison, 1955. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas, Ann. Surg. 142:709–723.
J. Rabinovitch, and S. Achs, 1943. Tumors of the islands of Langerhans, Arch. Pathol. 40:74.
S. Sailer, and M. M. Zinninger, 1946. Massive islet cell tumor of the pancreas without hypoglycemia, Surg. Gynecol. Obstet. 82:301.
R. Strom, 1952. A case of peptic ulcer and insulinoma, Acta. Chir. Scand. 104:252.
F. Forty, and G. Barett, 1952. Peptic ulceration of the third part of the duodenum associated with islet cell tumor of the pancreas, Br. J. Surg. 40:60.
J. E. Rhoads, September 13, 1999 (telephone conversation with John M. Howard).
T. E. Machella, J. E. Rhoads, and R. E. Hobler, 1949. Gastric hyperchlorhydria with three primary jejunal ulcers and hypoproteinemia. Case report, Gastroenterology 13:357–383.
B. Eiseman, 1956. Discussion of paper by: E. H. Ellison, The ulcerogenic tumor of the pancreas, Surgery 40:147.
R. A. Gregory, 1966. University of Liverpool memorial lecture: The isolation and chemistry of gastrin, Gastroenterology 51:953–959.
S. D. Wilson, and E. H. Ellison, 1966. Survival in patients with the Zollinger-Ellison syndrome treated by total gastrectomy, Am. J. Surg. 111:787–791.
J. E. McGuigan, and W. L. Trudeau, 1968. Immunochemical measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety, N. Eng. J. Med. 278:1308–1313.
J. E. McGuigan, and W. L. Trudeau, 1970. Studies with antibodies to gastrin radioimmunoassay in human serum and physiological studies, Gastroenterology 58:139-150.
H. A. Oberhelman, 1972. Excisional therapy for ulcerogenic tumors of the duodenum: Long term results, Arch. Surg. 104:447.
S. D. Wilson, 1987. Gastrinoma. Zollinger-Ellison syndrome, ulcerogenic tumor of the pancreas, in: Surgical Diseases of the Pancreas, 2nd ed. (J. M. Howard, G. L. Jordan, Jr., and H. A. Reber, eds.). Philadelphia: Lea and Febiger.
J. R. Murlin, H. D. Clough, C. B. F. Gibbs, and A. M. Stokes, 1923. Aqueous extracts of pancreas. Influence on the carbohydrate metabolism of depancreatized animals, J. Biol. Chem. 56:253–296.
E. W. Sutherland, and C. de Duve, 1948. Origin and distribution of hyperglycemic glycogenolytic factor of pancreas, J. Biol. Chem. 175:663–674.
A. Staub, L. Sinn, and O. K. Behrens, 1953. Purification and crystalization of hyperglycemic glycogenolytic factor (HGF), Science 117:628–629.
W. W. Brommer, L. G. Sinn, A. Staub, and O. K. Behrens, 1956. The molecular structure of glucagon, Am. J. Chem. Soc. 88:1988–1992.
A. Staub, L. G. Sinn, and O. K. Behrens, 1955. The synthesis of glucagon, J. Biol. Chem. 214:619-633.
M. S. Sabel, and R. A. Prinz, 1998. Glucagonoma, in: Surgical Diseases of the Pancreas, 3rd ed. (J. M. Howard, Y. Idezuki, I. Ihse, and R. A. Prinz, eds.). Philadelphia/Baltimore: Williams and Wilkins
S. W. Becker, D. Kahn, and S. Rothman, 1942. Cutaneous manifestations of internal malignant tumors, Arch. Dermatol. Syph. 45:1069.
A. O. Whipple, 1945. Pancreaticoduodenectomy for islet cell carcinoma, Ann. Surg. 121:847–852.
W. Hess, 1946. Über ein endokrin inaktives Karzinom der Langerhans’schen Inseln [A clinically inactive carcinoma of the islets of Langerhans], Schweiz. med. Wschr. 76:802.
. W. Gössner, and G.W. Korting, 1960. Metastasierendes Inselzellkarzinom vom AlphazellTyp bei einem Fall von Pemphigus foliaceus mit Diabetes renalis [Metastasizing islet carcinoma of the alpha cell type with foliaceous pemphigus and renal diabetes], Dtsch. med. Wschr. 85 :434–440.
R. H. Unger, A. M. Einsentraut, M. S. McCall, S. Keller, H. C. Lanz, and L. L. Madison, 1959. Glucagon antibodies and their use for immunoassay for glucagon, Proc. Soc. Exp. Biol. Med. 102:621–623.
R. H. Unger, A. M. Eisentraut, and J. D. V. Lochner, 1963. Glucagon-producing tumors of the islets of Langerhans, J. Clin. Invest. 42:987.
M. H. McGavran, R. H. Unger, L. Recant, H. C. Polk, C. Kilo, and M. E. Levin, 1966. A glucagon-secreting alpha-cell carcinoma of the pancreas, N. Engl. J. Med. 274:1408–1413.
J. P. Gardner, and J. J. Cerda, 1966. In vivo inhibition of intestinal fluid and electrolyte transport by non-beta islet cell tumor, Proc. Soc. Exp. Med. 123:361.
S. I. Said, and V. Mutt, 1972. Isolation from porcine intestinal wall of a vasoactive octasopeptide related to secretin and glucagon, Eur.J. Biochem. 18:199–204.
V. Mutt, and S. I. Said, 1974. Structure of the porcine vasoactive intestinal octacosapeptide. The amino acid sequence. Use of kallikrein in its discrimination, Eur. J. Biochem. 42:581–589.
J. V. Verner, and A. B. Morrison, 1958 Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia, Am.J. Med. 25:374.
W. M. Priest, and M. K. Alexander, 1957. Islet cell tumor of the pancreas with peptic ulceration, diarrhea and hypokalemia, Lancet 2:1145.
I. N. Marks, S. Bank, and J. H. Louw, 1967. Islet cell tumor of the pancreas with reversible watery diarrhea and achlorhydria, Gastroenterology 52:695.
K. K. Matsumoto, J. B. Peter, R. G. Schultze, H. A. Hakim, and P. T. Franck, 1966. Watery diarrhea and hypokalemia associated with pancreatic islet cell adenoma, Gastroenterology 50:231.
S. R. Bloom, and J. M. Polak, 1976. VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome, Clin. Endocrin. (Oxf.) 5(Suppl):223.
P. Brazeau, W. Vale, R. Burgus, N. Ling, M. Butcher, J. Rivier, and R. Guillemin, 1973. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone, Science 179:77–79.
O. P. Ganda, G. C. Weir, J. S. Soeldner, M. A. Legg, W. L. Chick, Y. C. Patel, A. M. Ebeid, K. H. Gabbay, and S. Reichlin, 1977. Somatostatinoma: A somatostatin containing tumor of the endocrine pancreas, N. Engl. J. Med. 296:963–967.
L. I. Larsson, M. A. Hirsch, J. J. Holst, S. Ingemansson, C. Kühl, S. L. Jensen, G. Lundqvist, J. F. Rehfeld, and T. W. Schwartz, 1977. Pancreatic somatostatinoma: Clinical features and physiological implications, Lancet 1:666–668.
C. Mao, A. Shah, D. J. Hanson, and J. M. Howard, 1995. Von Recklinghausen’s disease (VRD) associated with duodenal somatostatinomas (Contrast of duodenal versus pancreatic somatostatinomas), J. Surg. Oncol 59:67–73.
E. D. Staren, L. M. Gianakakis, and R. A. Prinz, 1998. Somatostatinoma, in: Surgical Diseases of the Pancreas, 3rd ed. (J. M. Howard, Y. Idezuki, I. Ihse, and R. A. Prinz, eds.). Philadelphia/ Baltimore: Williams and Wilkins.
S. Bonfils, 1974. General approach to fundamental and practical problems, Clin. Gastroenterol. 3:477–489.
A. G. E. Pearse, 1969. The cytochemistry and ultrastructure of polypeptide producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept, J. Histochem. Cytochem. 18:671–693.
P. Heitz, H. Steiner, F. Halter, P. Egli, and J. P. Kapp, 1971. Multihormonal amyloid producing tumors of the islets of Langerhans, Arch. Path. Anat 353:312.
S. R. Bloom, and J. M. Polak, 1978. Gut hormones overview, in: Gut Hormones (S. R. Bloom, ed.). Edinburgh: Churchill and Livingstone.
E. Elias, J. M. Polak, S. R. Bloom, and R. Wellbourn, 1972. Pancreatic cholera due to production of gastric inhibitory polypeptide, Lancet 2:791–792.
L. S. Semb, B. Fretheim, T. Freyland, and E. Gione, 1972. Gastric secretory inhibitor in the WDHA-syndrome, Arch. Franc. Mal. App. Dig. 61(Suppl 2):537c.
C. Y. Mao, L. Zhu, P. Carter, P. Schaefer, J. M. Dominguez, D. J. Hanson, H. E. Appert, and J. M. Howard, 1995. Malignant islet cell tumors associated with hypercalcemia (Report of three cases and review of the literature), Surgery 117:37–40.
R. H. Caplan, L. Koob, R. M. Abellera, A. S. Poglara, K. Kovacs, and R. V. Randall, 1978. Cure of acromegaly by operative removal of an islet cell tumor of the pancreas, Am. J. Med. 64:874–882.
R. Delcore, and S. R. Friesen, 1998. Other rare tumors of the endocrine pancreas, in: Surgical Diseases of the Pancreas, 3rd ed. (J. M. Howard, Y. Idezuki, I. Ihse, R. A. Prinz, eds.). Philadelphia/Baltimore: Williams and Wilkins.
J. Rivier, J. Spiess, M. Thorner, and W. Vale, 1982. Characterization of a growth hormone-releasing factor from a human pancreatic islet cell tumour, Nature 300:276–278.
R. Guillemin, P. Brazeau, P. Bohlen, F. Esch, and N. Ling, 1982. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly, Science 218:585–587.
G. Lundqvist, U. Krause, L. I. Larsson, L. Grimelius, O. B. Schaffalitzky de Mukadell, O. Fahrenkrug, M. Hohnson, and R. E. Chance, 1978. A pancreatic polypeptide-producing tumour associated with the WDHA-syndrome, Scand. J. Gastroent. 13:715–718.
C. Bordi, R. Togni, D. Baetens, M. Ravazzola, F. Malaisse, L. Agae, and L. Orci, 1978 Human islet cell tumor storing pancreatic polypeptide, J. Clin. Endocrinol. Metabol. 46:215–219.
R. E. Chance, and W. E. Jones, 1974. Polypeptides from bovine, ovine, human and porcine pancreas, US Patent Office 842:063.
M. Gutniak, U. Rosenqvist, L. Grimelius, J. M. Lundberg, T. Hokfelt, A. Rokaeus, S. Rosell, G. Lundquist, J. Fahrenkrug, R. Sundblad, and E. Gutniak, 1980. Report on a patient with watery diarrhea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin, Acta Med. Scand. 208:95–100.
P. U. Heitz, G. Klöppel, J. M. Polak, and J. J. Staub, 1981. Ectopic hormone production by endocrine tumors: localization of hormones at the cellular level by immunocytochemistry, Cancer 48:2029.
K. Oberg, L. Loof, H. Bostrom, L. Grimelius, J. Fahrenkrug, and G. Lundqvist, 1981. Hypersecretion of calcitonin in patients with the Verner-Morrison syndrome, Scand. J. Gastroent. 16:135–144.
T. J. McDonald, G. Nilsson, M. Vagne, M. Ghatei, S. R. Bloom, and V. Mutt, 1978. A gastrin releasing peptide from the non-antral gastric tissue, Gut 19:767–774.
G. Somers, O. Segers, M. Maarichal, P. in’t Veld, and G. Klöppel, 1989. Pancreatic bombesinoma, Eur. J. Clin. Invest. 19:A34.
S. D. Wilson, K. Soergel, and V. L W. Go, 1973. Diarrhea, gastric hypersecretion and cholecystokinin-like hormone, Lancet 1:1515–1516.
H. T. Debbas, and S. J. Mulvihil, 1994. Neuroendocrine gut neoplasms; important lessons from uncommon tumors, Arch. Surg. 129:965–972.
J. A. Chayvialle, J. C. Cuber, C. Partensky, F. Berger, and C. Bernard, 1990. Pseudo-Zollinger Ellison syndrome with pancreatic tumor, storing cholecystokinin-like immunoreactivity, Eur. Gastroenterot. Club 37:260.
P. Westermark, C. Wernstedt, E. Wilander, and K. Sletten, 1986. A novel peptide in the calcitonin gene related peptide as an amyloid fibril protein in the endocrine pancreas, Biochem. Biophys. Res. Commun. 140:827–831.
P. Westermark, C. Wernstedt, E. Wilander, D. W. Hayden, T. D. O’Brien, and K. H. Johnson, 1987. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells, Proc. Natl. Acad. Sci. U.S.A. 84:3881–3885.
G. J. Cooper, A. J. Day, A. C. Willis, A. N. Roberts, K. B. M. Reid, and B. Leighton, 1989. Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus, Biochim. Biophys. Acta 1014:247–258.
M. Stridsberg, E. Wilander, K. Oberg, G. Lundqvist, and B. Eriksson, 1992. Islet amyloid polypeptide-producing pancreatic islet cell tumor. A clinical and biochemical characterization, Scand. J. Gastroent 27:381–387.
E. J. Kepler, 1933. Report of four cases, Proc. Staff Mtgs. Mayo Clinic 8:102–107.
X. Bertagna, C. Favrod-Coune, H. Escourolle, P. Beuzebroc, B. Christoforov, F. Girard, and J. P. Luton, 1989. Suppression of ectopic adrenocorticotropin secretion by the long-acting somata statin analog octreotide, J. Clin. Endocrinol. Metab. 66:988–991.
F. Merling, 1838. Anatomie pathologique de l’appendice du caecum [Pathological anatomy of the appendix of the cecum], Experientia (Paris) 1:337.
. W. S. Peart, K. A. Porter, J. I. Robertson, M. Sandler, and E. Baldock, 1963. Carcinoid syndrome due to pancreatic duct neoplasm secreting 5-hydroxytryptophan and 5-hydroxytryptamine, Lancet 1 :239–243.
C. Mao, A. El Attar, D. R. Domenico, K. Kim, and J. M. Howard, 1998. Carcinoid tumors of the pancreas. Status report based on two cases and review of the world’s literature, Int. J. Pancreatol. 23:153–164.
P. Wermer, 1954. Genetic aspects of adenomatosis of the endocrine glands, Am. J. Med. 16:363.
W. Pagel (ed), 1930. Lexikon hervorragender Ärate, 6 volumes. Berlin-Wien: Urban and Schwarzenberg.
W. Schulze, 1900. Die Bedeutung der Langerhanschen Inseln [The significance of the islets of Langerhans], Arch. mikrosk Anat. Entwicklungsgesch. 56:491–509.
J. R. Brooks (ed.), 1983. Surgery of the Pancreas. Philadelphia: W. B. Saunders.
MMW Medizinverlag, 1909. Supplement, Münchner Medizinische Wochenschrift 56.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Howard, J.M., Hess, W. (2002). The Endocrine Pancreas. In: History of the Pancreas: Mysteries of a Hidden Organ. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0555-6_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0555-6_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5130-6
Online ISBN: 978-1-4615-0555-6
eBook Packages: Springer Book Archive